BAY-299 is primarily utilized in the field of pharmaceutical research and development, particularly in the study of enzyme inhibition and its potential therapeutic applications. It is often investigated for its role in modulating specific biological pathways, which could lead to the development of novel treatments for various diseases. Researchers focus on its efficacy and safety profile in preclinical studies, aiming to identify its potential as a drug candidate. Additionally, it is used in biochemical assays to better understand its mechanism of action and interactions with target proteins, contributing to advancements in medicinal chemistry and drug discovery.